Learning Objectives

1. Examine the cultural barriers that hinder the adequate delivery and use of mental health care services for the treatment of depression among minority populations incorporating methods of early detection and prevention of unipolar depression.

2. Review the indications and efficacy of available pharmacologic and psychotherapeutic treatment options for depression

3. Describe methods to determine the treatment strategies that are best suited for specific patient populations.

4.Explain the factors that constitute barriers to full functional recovery from depression including medication side effect management, cognitive impairment and optimal multimodal therapy strategies. 

Agenda

Saturday, February 27, 2010

7:30AM – 8:00AM	Registration and Continental Breakfast
8:00AM – 8:15AM	Welcome and Opening Remarks
8:15AM – 9:05AM	Optimizing Pharmacotherapy in Major Depressive Disorder Dr. Maurizio Fava & Dr. Stella Bitran
9:05AM – 10:20AM	Cases from Clinical Practice About Treatment Disruptions: An Interactive Dialogue with Audience Participation Dr. Maurizio Fava and Dr. Stella Bitran
10:20AM – 10:35AM	BREAK
10:35AM – 11:25AM	Integrating Psychotherapy and Psychopharmacology: Encompassing Cultural Considerations Dr. Albert Yeung
11:25AM – 12:15PM	Side Effect Management, Cognitive Dysfunction & Residual Symptoms Dr. David Mischoulon
12:15PM – 12:50PM	Post-Activity Questions & Panel Discussion All faculty
12:50PM – 1:30PM	LUNCH

Faculty

Maurizio Fava, MD
Professor of Psychiatry, Harvard Medical School; Associate Chief of Psychiatry for Clinical Research, Psychiatrist and Director, Depression Clinical and Research Program, Massachusetts General Hospital.

David Mischoulon, MD, PhD
Director, Alternative Remedy Studies, The Depression Clinical and Research Program, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School

Albert Yeung, MD, ScD
Assistant Psychiatrist, Massachusetts General Hospital; Assistant Professor of Psychiatry, Harvard Medical School

Stella Bitran, PhD
Clinical and Research Fellow in the Depression Clinical and
Research Program (DCRP)
Massachusetts General Hospital
Clinical Fellow
Harvard Medical School

Accreditation

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital, Massachusetts General Hospital Academy and Reed Medical Education. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.
Credit Designation
McLean Hospital designates this continuing medical educational activity for a maximum of 4.5 AMA PRA Category 1 Credits(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Supporters

Our evidence-based curriculum is supported by educational grants from:

• 
  
• 
  
•